Yildiz Munise, Tavlan Aybars, Tuncer Sema, Reisli Ruhiye, Yosunkaya Alper, Otelcioglu Seref
Department of Anaesthesiology, Medical Faculty, University of Selcuk of Meram, Konya, Turkey.
Drugs R D. 2006;7(1):43-52. doi: 10.2165/00126839-200607010-00004.
Dexmedetomidine reduces the dose requirements for opioids and anaesthetic agents. The purpose of this study was to evaluate the effect of a single pre-induction intravenous dose of dexmedetomidine 1 microg/kg on cardiovascular response resulting from laryngoscopy and endotracheal intubation, need for anaesthetic agent and perioperative haemodynamic stability.
Fifty patients scheduled for elective minor surgery were randomised into two groups (dexmedetomidine group and placebo group, n = 25 in each group). During and after drug administration, the Ramsey sedation scale was applied every 5 minutes. Fentanyl 1 microg/kg was administered to all patients and thiopental was given until lash reflex disappeared. Anaesthesia continuation was maintained with 50% : 50%, oxygen : nitrous oxide. Sevoflurane concentration was adjusted to maintain systolic blood pressure within 20% of preoperative values. After extubation, the Steward awakening score was applied at 5 and 10 minutes. Haemodynamic parameters and adverse effects were recorded every 10 minutes for 1 hour after surgery.
During intubation the need for thiopental and sevoflurane concentration were decreased by 39% and 92%, respectively, in the dexmedetomidine group compared with the placebo group. In all groups, blood pressure and heart rate increased after tracheal intubation; both were significantly lower in the dexmedetomidine group than in the placebo group (p < 0.05). Fentanyl requirement during the operation was 74.20 +/- 10.53microg in the dexmedetomidine group and 84.00 +/- 27.04microg in the placebo group (p < 0.05). At 5 minutes, the Steward scores were >6 in 56% of the dexmedetomidine group and in 4% of the placebo group (p < 0.05). At 10 minutes, sedation scores were > or =4 in all patients in the dexmedetomidine group (p < 0.05). Arterial blood pressure and heart rate in the postoperative period were significantly lower in the dexmedetomidine group compared with the placebo group (p < 0.05).
Preoperative administration of a single dose of dexmedetomidine resulted in progressive increases in sedation, blunted the haemodynamic responses during laryngoscopy, and reduced opioid and anaesthetic requirements. Furthermore, dexmedetomidine decreased blood pressure and heart rate as well as the recovery time after the operation.
右美托咪定可降低阿片类药物和麻醉剂的用量。本研究旨在评估诱导前静脉注射单次剂量1微克/千克右美托咪定对喉镜检查和气管插管引起的心血管反应、麻醉剂需求及围手术期血流动力学稳定性的影响。
50例择期行小手术的患者被随机分为两组(右美托咪定组和安慰剂组,每组n = 25)。给药期间及给药后,每5分钟应用拉姆齐镇静评分。所有患者均给予1微克/千克芬太尼,并给予硫喷妥钠直至睫毛反射消失。采用50%氧气:50%氧化亚氮维持麻醉。调整七氟醚浓度以使收缩压维持在术前值的20%以内。拔管后,在5分钟和10分钟应用Steward苏醒评分。术后1小时内每10分钟记录血流动力学参数和不良反应。
与安慰剂组相比,右美托咪定组在插管期间硫喷妥钠需求和七氟醚浓度分别降低了39%和92%。在所有组中,气管插管后血压和心率均升高;右美托咪定组两者均显著低于安慰剂组(p < 0.05)。右美托咪定组术中芬太尼需求量为74.20±10.53微克,安慰剂组为84.00±27.04微克(p < 0.05)。5分钟时,右美托咪定组56%的患者Steward评分>6,安慰剂组为4%(p < 0.05)。10分钟时,右美托咪定组所有患者的镇静评分≥(大于或等于)4(p < 0.05)。与安慰剂组相比,右美托咪定组术后动脉血压和心率显著降低(p < 0.05)。
术前单次给予右美托咪定可使镇静作用逐渐增强,减弱喉镜检查期间的血流动力学反应,并降低阿片类药物和麻醉剂的需求量。此外,右美托咪定可降低血压和心率以及术后恢复时间。